Segall Bryant & Hamill LLC purchased a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 36,987 shares of the company's stock, valued at approximately $297,000. Segall Bryant & Hamill LLC owned about 0.09% of Viemed Healthcare at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its position in shares of Viemed Healthcare by 748.2% during the third quarter. Victory Capital Management Inc. now owns 108,497 shares of the company's stock worth $795,000 after purchasing an additional 95,706 shares during the last quarter. BBR Partners LLC bought a new stake in Viemed Healthcare during the 3rd quarter valued at about $110,000. Martingale Asset Management L P boosted its position in Viemed Healthcare by 28.5% in the 3rd quarter. Martingale Asset Management L P now owns 31,385 shares of the company's stock valued at $230,000 after buying an additional 6,965 shares during the period. Walleye Capital LLC bought a new position in Viemed Healthcare in the 3rd quarter worth about $87,000. Finally, PDT Partners LLC purchased a new position in shares of Viemed Healthcare during the third quarter worth approximately $78,000. Institutional investors own 74.24% of the company's stock.
Viemed Healthcare Trading Down 1.4 %
Shares of Viemed Healthcare stock traded down $0.10 on Tuesday, hitting $7.18. 20,951 shares of the company traded hands, compared to its average volume of 135,780. Viemed Healthcare, Inc. has a 52 week low of $6.21 and a 52 week high of $9.81. The company has a market cap of $283.73 million, a PE ratio of 26.54 and a beta of 1.50. The stock's 50 day moving average price is $7.80 and its 200-day moving average price is $8.19. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03.
Viemed Healthcare Company Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Stories
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
